[Complications of therapy of advanced stages Parkinson's disease and possible approaches to their correction].
Golubev
V L
VL
D000978:Antiparkinson Agents / Q000009:adverse effects*; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced* / Q000517:prevention & control; D001523:Mental Disorders / Q000139:chemically induced* / Q000517:prevention & control; D010300:Parkinson Disease / Q000188:drug therapy*; D011596:Psychomotor Disorders / Q000139:chemically induced* / Q000517:prevention & control
D000978:Antiparkinson Agents